Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 12/20 | 0.46 |
| ▸ | MTOR | P42345 | 6/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.45 |
| ▸ | PIK3R1 | P27986 | 9/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.45 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.45 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14960380 | 0.86 | MTOR (0.55) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL1114005 | 0.86 | MTOR (0.51) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL799551 | 0.86 | MTOR (0.51) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL799437 | 0.85 | MTOR (0.51) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL1114284 | 0.84 | HDAC1 (0.52) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL799510 | 0.84 | MTOR (0.52) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL1114167 | 0.83 | HDAC1 (0.56) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL799241 | 0.82 | MTOR (0.49) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL9605491 | 0.81 | MTOR (0.45) | PIK3CAMTORHDAC1PIK3R1PIK3CD | |
| SCHEMBL1114353 | 0.81 | MTOR (0.48) | PIK3CAMTORHDAC1PIK3R1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120135988-A1 | PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | CASTANEDO GEORGETTE (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135988-A1 | PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | PIK3CA, PIK3CD, PIK3CG | PIK3CA 1/4885MTOR 75/4885HDAC1 3176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.